Lisa Jo Reboton

Lisa Jo Reboton has over twenty years of work experience in the pharmaceutical industry. Lisa Jo began their career in 1998 as a Senior Research Associate at Elan Pharmaceuticals (formally Dura Pharmaceuticals), where they performed stability, release, and product development testing of dry powder formulations for inhalation in a cGMP pharmaceutical laboratory. In 2002, they moved to SkyePharma Inc. (currently Pacira Pharmaceuticals) as a Senior Research Associate in the Quality Control department, where they performed in-process, release, stability, and product development testing for injectable sustained-release final product. In 2007, they joined Pfizer - CovX Research Unit as a Scientist in Analytical Development, where they developed analytical methods for the characterization of antibody peptide conjugates and antibody drug conjugates. In 2013, they moved to Sorrento Therapeutics, Inc. as a Scientist, where they developed analytical methods for the characterization of antibodies and antibody drug conjugates. In 2014, they joined SOLSTICE BIOLOGICS USA, INC. as a Scientist, where they developed and performed analytical methods for the characterization of oligonucleotides (siRNA and DNA) and oligonucleotide-antibody conjugates. In 2018, they joined Eurofins Advantar as a Senior Scientist/Group Leader/Associate Director, where they acquired and developed analytical methods for the characterization of small molecules, proteins, and antibodies in a cGMP laboratory. Most recently, they joined Design Therapeutics as a Sr. Manager of Product Development in 2022.

Lisa Jo Reboton completed their Bachelor of Science in Chemistry from UC San Diego in 1996.